Product Information
DEBLITANE 0.35 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.0924 per EA under NDC 16714044004. Its NADAC has been published 622 times since Nov 5, 2014.
FDA first approved this application on Sep 13, 2013. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
NorthStar Rx LLCNDC
16714044004
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202014FDA Approved
9/13/2013
TE Code
AB1
On Market Since
9/13/2013
Price Statistics
The NADAC for DEBLITANE 0.35 MG TABLET has been published 622 times since Nov 5, 2014, and over the history we have for it it has declined 84.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0924 per EA |
|---|---|
| All-time high | $0.6358 (Dec 10, 2014) |
| All-time low | $0.0691 (Nov 20, 2024) |
| 52-week high | $0.0945 |
| 52-week low | $0.0849 |
| Median price | $0.1984 |
| Average price | $0.2368 |
| Largest weekly change | +43.4% (Aug 21, 2024) |
| Weeks tracked | 622 |
| Tracking since | Nov 5, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEBLITANE 0.35 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEBLITANE 0.35 MG TABLET, manufactured by NorthStar Rx LLC, is $0.0924 per EA (NDC 16714044004), effective Sep 30, 2026.
How has the price of DEBLITANE 0.35 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEBLITANE 0.35 MG TABLET has declined 84.1%. It has been tracked across 622 weekly CMS publications since Nov 5, 2014.
What are the highest and lowest recorded NADAC prices for DEBLITANE 0.35 MG TABLET?
Since Nov 5, 2014, the NADAC for DEBLITANE 0.35 MG TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.6358 (Dec 10, 2014), with a median of $0.1984 per EA.
Are there cheaper alternatives to DEBLITANE 0.35 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEBLITANE 0.35 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DEBLITANE 0.35 MG TABLET?
DEBLITANE 0.35 MG TABLET (NDC 16714044004) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.